Detalhe da pesquisa
1.
Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
Toxicol Appl Pharmacol
; 285(1): 51-60, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25841593
2.
Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes.
Toxicol Appl Pharmacol
; 272(1): 245-55, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23707608
3.
Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.
BMC Cell Biol
; 10: 32, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19409099
4.
Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression.
Cell Transplant
; 15(8-9): 785-98, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17269449
5.
A multi-parameter in vitro screen in human stem cell-derived cardiomyocytes identifies ponatinib-induced structural and functional cardiac toxicity.
Toxicol Sci
; 143(1): 147-55, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304212
6.
KRAS mutation status is associated with enhanced dependency on folate metabolism pathways in non-small cell lung cancer cells.
Mol Cancer Ther
; 13(6): 1611-24, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24688052
7.
Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.
PLoS One
; 8(8): e72407, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23967299
8.
Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cells.
Mol Cancer Ther
; 9(4): 895-905, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371712
9.
Transient nutlin-3a treatment promotes endoreduplication and the generation of therapy-resistant tetraploid cells.
Cancer Res
; 68(20): 8260-8, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18922897
10.
Molecular pathogenesis of hepatocellular carcinoma.
J Surg Res
; 136(1): 125-35, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17023002
11.
Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Liver Int
; 25(2): 445-57, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15780071